Literature DB >> 26529279

Lipolytic and thermogenic depletion of adipose tissue in cancer cachexia.

Maria Tsoli1, Michael M Swarbrick2, Graham R Robertson3.   

Abstract

Although muscle wasting is the obvious manifestation of cancer cachexia that impacts on patient quality of life, the loss of lipid reserves and metabolic imbalance in adipose tissue also contribute to the devastating impact of cachexia. Depletion of fat depots in cancer patients is more pronounced than loss of muscle and often precedes, or even occurs in the absence of, reduced lean body mass. Rapid mobilisation of triglycerides stored within adipocytes to supply the body with fatty acids in periods of high-energy demand is normally mediated through a well-defined process of lipolysis involving the lipases ATGL, HSL and MGL. Studies into how these lipases contribute to fat loss in cancer cachexia have revealed the prominent role for ATGL in initiating lipolysis during adipose tissue atrophy, together with links between tumour-derived factors and the signalling pathways that control lipid flux within fat cells. The recent findings of increased thermogenesis in brown fat during cancer cachexia indicate that metabolically active adipose tissue contributes to the imbalance in energy homeostasis involved in catabolic wasting. Such energetically futile use of fatty acids liberated from adipose tissue to generate heat represents a maladaptive response in conjunction with anorexia experienced by cancer patients. As IL-6 release by tumours provokes lipolysis and activates the thermogenic programme in brown fat, this review explores the overlap in dysregulated metabolic processes due to inflammatory mediators in cancer cachexia and other disease states characterised by elevated cytokines such as obesity and diabetes. Crown
Copyright © 2015. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adipose tissue; Brown fat; Cancer cachexia; IL-6; Lipolysis; Thermogenesis

Mesh:

Year:  2015        PMID: 26529279     DOI: 10.1016/j.semcdb.2015.10.039

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  35 in total

1.  Does the Poly (ADP-Ribose) Polymerase Inhibitor Veliparib Merit Further Study for Cancer-Associated Weight Loss? Observations and Conclusions from Sixty Prospectively Treated Patients.

Authors:  Jason D Doles; Kelly A Hogan; Jennifer O'Connor; Andrea E Wahner Hendrickson; Olivia Huston; Aminah Jatoi
Journal:  J Palliat Med       Date:  2018-05-24       Impact factor: 2.947

2.  Inability to replete white adipose tissue during recovery phase of sepsis is associated with increased autophagy, apoptosis, and proteasome activity.

Authors:  Kristen T Crowell; David I Soybel; Charles H Lang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-01-18       Impact factor: 3.619

Review 3.  STAT3 in the systemic inflammation of cancer cachexia.

Authors:  Teresa A Zimmers; Melissa L Fishel; Andrea Bonetto
Journal:  Semin Cell Dev Biol       Date:  2016-02-06       Impact factor: 7.727

Review 4.  The Molecular Basis and Therapeutic Potential of Leukemia Inhibitory Factor in Cancer Cachexia.

Authors:  Ruijiang Zeng; Chang Tong; Xiangyang Xiong
Journal:  Cancers (Basel)       Date:  2022-06-15       Impact factor: 6.575

5.  Cytokine-Mediated STAT3 Transcription Supports ATGL/CGI-58-Dependent Adipocyte Lipolysis in Cancer Cachexia.

Authors:  Aakash Y Gandhi; Jinhai Yu; Arun Gupta; Tong Guo; Puneeth Iyengar; Rodney E Infante
Journal:  Front Oncol       Date:  2022-06-15       Impact factor: 5.738

6.  An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice.

Authors:  Maria Rohm; Michaela Schäfer; Victor Laurent; Bilgen Ekim Üstünel; Katharina Niopek; Carolyn Algire; Oksana Hautzinger; Tjeerd P Sijmonsma; Annika Zota; Dasa Medrikova; Natalia S Pellegata; Mikael Ryden; Agné Kulyte; Ingrid Dahlman; Peter Arner; Natasa Petrovic; Barbara Cannon; Ez-Zoubir Amri; Bruce E Kemp; Gregory R Steinberg; Petra Janovska; Jan Kopecky; Christian Wolfrum; Matthias Blüher; Mauricio Berriel Diaz; Stephan Herzig
Journal:  Nat Med       Date:  2016-08-29       Impact factor: 53.440

7.  SiBaoChongCao exhibited anti-fatigue activities and ameliorated cancer cachexia in mice.

Authors:  Qiang Shen; Chun-Xiao Miao; Wan-Li Zhang; Yi-Wei Li; Qiao-Qiao Chen; Xiao-Xiang Li; Xuan Liu; Xiong-Wen Zhang
Journal:  RSC Adv       Date:  2019-06-04       Impact factor: 4.036

8.  The Level of Serum Cholesterol is Negatively Associated with Lean Body Mass in Korean non-Diabetic Cancer Patients.

Authors:  Ji Eun Han; Jun Yeup Lee; So Young Bu
Journal:  Clin Nutr Res       Date:  2016-04-30

9.  Is Cancer Cachexia Attributed to Impairments in Basal or Postprandial Muscle Protein Metabolism?

Authors:  Astrid M H Horstman; Steven W Olde Damink; Annemie M W J Schols; Luc J C van Loon
Journal:  Nutrients       Date:  2016-08-16       Impact factor: 5.717

Review 10.  Mechanisms of metabolic dysfunction in cancer-associated cachexia.

Authors:  Michele Petruzzelli; Erwin F Wagner
Journal:  Genes Dev       Date:  2016-03-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.